No Picture
Trading Ideas

Bayer Dicamba Sales Blocked by U.S. Court on Herbicide Risk

(Bloomberg) — Bayer AG is blocked from selling its controversial dicamba-based herbicide in the U.S. after an appeals court rejected a federal regulator’s permit for the product, compounding the German company’s weed-killer woes.The three-judge panel concluded the Environmental Protection Agency had “failed entirely” to acknowledge some risks dicamba poses and that the agency violated federal regulations when it extended its approval of registration for the herbicide for another two years in October 2018.The ruling means farmers who bought seeds to be used with dicamba for this year’s growing season may not be able to plant them, since pesticides can’t be …read more […]

No Picture
Trading Ideas

Amazon Leases 12 Boeing Cargo Aircraft To Meet Online Orders Surge

Amazon.com Inc. (AMZN) said it is leasing an additional 12 Boeing (BA) 767-300 converted cargo aircraft as the e-commerce giant seeks to make delivery times faster amid an increase in online orders.One of the new aircraft joined Amazon’s air cargo operations in May, and the remaining 11 are expected to be delivered in 2021. These aircraft will be added to Amazon’s existing fleet of 70 aircraft.“Amazon Air is critical to ensuring fast delivery for our customers – both in the current environment we are facing, and beyond,” said Sarah Rhoads, VP of Amazon Global Air. “During a time when so …read more […]

No Picture
Trading Ideas

5 Promising Covid-19 Vaccines Now Selected For Trump’s Operation Warp Speed

Five companies have now been picked by the Trump administration as the most likely candidates to produce a coronavirus vaccine, The New York Times reports.This comes as part of Operation Warp Speed (OWS), the administration’s national program to accelerate the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics.Among its other objectives, Operation Warp Speed aims to have substantial quantities of a safe and effective vaccine available for Americans by January 2021.The five companies selected are as follows:Moderna’s (MRNA) mRNA1273 which is currently undergoing Phase 2 trials;A joint collaboration between AstraZeneca (AZN) and Oxford University on AZD1222 which is …read more […]